Robert W. Baird Raises Illumina (NASDAQ:ILMN) Price Target to $128.00
Illumina (NASDAQ:ILMN – Free Report) had its price target lifted by Robert W. Baird from $125.00 to $128.00 in a research report report published on Friday morning, Benzinga reports. The brokerage currently has a neutral rating on the life sciences company’s stock. Several other equities research analysts have also issued reports on ILMN. TD Cowen […]